Cited by 455Cancer-related Molecular PathwaysHeat shock proteins researchDNA Repair Mechanisms

Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2

Open access
Dumaz, Nicolas, Meek, David W.·1999·The EMBO Journal

Abstract

The p53 tumour suppressor protein is a labile transcription factor that is activated and stabilized in response to a wide range of cellular stresses, through a mechanism involving disruption of its interaction with MDM2, a negative regulatory partner. Induction of p53 by DNA damage additionally involves a series of phosphorylation and acetylation modifications, some of which are thought to regulate MDM2 binding. Here we report the effects of introducing mutations at several known or putative N-terminal phosphorylation sites on the transactivation function of p53. These studies highlight phosphorylation of Ser15, a key phosphorylation target during the p53 activation process, as being critical for p53-dependent transactivation. Biochemical data indicate that the mechanism by which phosphorylation of Ser15 stimulates p53-dependent transactivation occurs through increased binding to the p300 coactivator protein. The data also indicate that Ser15-dependent regulation of transactivation is independent of any involvement in modulating MDM2 binding, and that Ser15 phosphorylation alone is not sufficient to block the p53-MDM2 interaction.

Integrity signals

Registry

Crossref · 10.1093/emboj/18.24.7002

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutation of multiple p53 phosphorylation sites including S15 and S20 did not abrogate p53 stabilization after DNA damage in cell culture.

    “Mutation of multiple phosphorylation sites including S15 and S20 did not abrogate p53 stabilization after DNA damage in cell culture (Ashcroft et al, 1999;Blattner et al, 1999;Dumaz and Meek, 1999).”

    From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Dumaz and Meek, 1999

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dumaz, N., & Meek, D. W.
Affiliations
University of Dundee (GB)
Corresponding author
Meek, David W.
Venue
The EMBO Journal
Published
1999-12-15
Volume
18
Issue
24
Pages
7002-7010
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2098935972
Cited by
455
References
55
Citations by year
2026: 6 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 6 · 2021: 1 · 2020: 5 · 2019: 9 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 18 · 2013: 22 · 2012: 17
FWCI
12.41
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
Funders
  • Directorate for Biological Sciences
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
p53, transcriptional activation, MDM2, p300 coactivator, p53-MDM2 interaction, DNA damage response, tumour suppressor
MeSH terms
Cell Line, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphoserine, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Recombinant Proteins, Serine, Transfection, Transcriptional Activation, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Genes, Reporter, Amino Acid Substitution, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review